![Frontiers | Deep Brain Stimulation and L-DOPA Therapy: Concepts of Action and Clinical Applications in Parkinson's Disease Frontiers | Deep Brain Stimulation and L-DOPA Therapy: Concepts of Action and Clinical Applications in Parkinson's Disease](https://www.frontiersin.org/files/Articles/391669/fneur-09-00711-HTML/image_m/fneur-09-00711-g001.jpg)
Frontiers | Deep Brain Stimulation and L-DOPA Therapy: Concepts of Action and Clinical Applications in Parkinson's Disease
![Spectroscopic study of L-DOPA and dopamine binding on novel gold nanoparticles towards more efficient drug-delivery system for Parkinson's disease - ScienceDirect Spectroscopic study of L-DOPA and dopamine binding on novel gold nanoparticles towards more efficient drug-delivery system for Parkinson's disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1386142521012841-ga1.jpg)
Spectroscopic study of L-DOPA and dopamine binding on novel gold nanoparticles towards more efficient drug-delivery system for Parkinson's disease - ScienceDirect
![Biosensors | Free Full-Text | Differential Amperometric Microneedle Biosensor for Wearable Levodopa Monitoring of Parkinson’s Disease | HTML Biosensors | Free Full-Text | Differential Amperometric Microneedle Biosensor for Wearable Levodopa Monitoring of Parkinson’s Disease | HTML](https://www.mdpi.com/biosensors/biosensors-12-00102/article_deploy/html/images/biosensors-12-00102-g001.png)
Biosensors | Free Full-Text | Differential Amperometric Microneedle Biosensor for Wearable Levodopa Monitoring of Parkinson’s Disease | HTML
![Simple and rapid detection of l-dopa based on in situ formation of polylevodopa nanoparticles - ScienceDirect Simple and rapid detection of l-dopa based on in situ formation of polylevodopa nanoparticles - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0925400516320226-fx1.jpg)
Simple and rapid detection of l-dopa based on in situ formation of polylevodopa nanoparticles - ScienceDirect
![DOPA End of Season 11 Talk [1/2]- Why he couldn't hit #1, power of Chovy and Showmaker : r/leagueoflegends DOPA End of Season 11 Talk [1/2]- Why he couldn't hit #1, power of Chovy and Showmaker : r/leagueoflegends](https://external-preview.redd.it/jn4KLxE2mm6td30qs3pcRm7ouiku2xKiExlW6PxLMAc.jpg?auto=webp&s=14a5da2eec8feca83edcc85e65b1600996905eb5)
DOPA End of Season 11 Talk [1/2]- Why he couldn't hit #1, power of Chovy and Showmaker : r/leagueoflegends
![L-DOPA-quinone Mediated Recovery from GIRK Channel Firing Inhibition in Dopaminergic Neurons | ACS Medicinal Chemistry Letters L-DOPA-quinone Mediated Recovery from GIRK Channel Firing Inhibition in Dopaminergic Neurons | ACS Medicinal Chemistry Letters](https://pubs.acs.org/cms/10.1021/acsmedchemlett.8b00477/asset/images/medium/ml-2018-004772_0001.gif)
L-DOPA-quinone Mediated Recovery from GIRK Channel Firing Inhibition in Dopaminergic Neurons | ACS Medicinal Chemistry Letters
L-DOPA-quinone Mediated Recovery from GIRK Channel Firing Inhibition in Dopaminergic Neurons | ACS Medicinal Chemistry Letters
![Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases | PNAS Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases | PNAS](https://www.pnas.org/cms/10.1073/pnas.1111456108/asset/ddb892c0-b9ca-4314-b7b6-083511e2cfad/assets/graphic/pnas.1111456108fig3.jpeg)
Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases | PNAS
![Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration - The American Journal of Medicine Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration - The American Journal of Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f4e96ee5-fbb6-4190-b35f-b96b1a00e78a/gr1.jpg)
Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration - The American Journal of Medicine
![RasGRP1 is a causal factor in the development of l-DOPA–induced dyskinesia in Parkinson's disease | Science Advances RasGRP1 is a causal factor in the development of l-DOPA–induced dyskinesia in Parkinson's disease | Science Advances](https://www.science.org/cms/10.1126/sciadv.aaz7001/asset/b84e3733-fe02-4175-8e7c-290177df2d25/assets/graphic/aaz7001-f1.jpeg)
RasGRP1 is a causal factor in the development of l-DOPA–induced dyskinesia in Parkinson's disease | Science Advances
![Enhanced striatal cholinergic neuronal activity mediates l-DOPA–induced dyskinesia in parkinsonian mice | PNAS Enhanced striatal cholinergic neuronal activity mediates l-DOPA–induced dyskinesia in parkinsonian mice | PNAS](https://www.pnas.org/cms/10.1073/pnas.1006511108/asset/ced33242-1c07-4043-b866-864dd94edefe/assets/graphic/pnas.1006511108fig06.jpeg)
Enhanced striatal cholinergic neuronal activity mediates l-DOPA–induced dyskinesia in parkinsonian mice | PNAS
![Novel Inhibitors of Human DOPA Decarboxylase Extracted from Euonymus glabra Roxb. | ACS Chemical Biology Novel Inhibitors of Human DOPA Decarboxylase Extracted from Euonymus glabra Roxb. | ACS Chemical Biology](https://pubs.acs.org/cms/10.1021/cb500009r/asset/images/medium/cb-2014-00009r_0001.gif)
Novel Inhibitors of Human DOPA Decarboxylase Extracted from Euonymus glabra Roxb. | ACS Chemical Biology
![Visualizing Neuromodulation In Vivo: TANGO-Mapping of Dopamine Signaling Reveals Appetite Control of Sugar Sensing: Cell Visualizing Neuromodulation In Vivo: TANGO-Mapping of Dopamine Signaling Reveals Appetite Control of Sugar Sensing: Cell](https://www.cell.com/cms/attachment/2007964580/2030740327/fx1.jpg)